Continuing Education

Continuing Medical Education Conference

 
"A Review of the Most Recent Developments in Cancer Therapy"
November 6th 2010
Doubletree Hotel by the Galleria
 
ACCREDITATION AND CREDITS

EXCEL Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.

EXCEL Continuing Education designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Physician Assistants:  AAPA accepts AMA Category 1 Credit™ from organizations accredited by the ACCME.

Nurse Practitioners:  AANP accepts AMA Category 1 Credit™ from organizations accredited by the ACCME.

Nurses: EXCEL Continuing Education is accredited by the FL Board of Nursing Provider # 50-619 and designates this activity for 4 nursing contact hours.

 

EDUCATIONAL OBJECTIVES

Upon completion of this activity, you should be able to:

  • Interpret current controversies and examine established technologies in the management of several solid tumor malignancies.
  • Review ongoing clinical trials, research and expert analysis of issues focused on solid tumor malignancies and the potential impact of the findings of these studies on your clinical practice.
  • Integrate evidence-based approach and expert opinion in the management of these diseases in order to improve the outcomes of your patients.

 

TARGET AUDIENCE / PROGRAM OVERVIEW / NEEDS ASSESSEMENT

This live activity has been designed to meet the educational needs of healthcare providers who diagnose and treat patients with solid tumor malignancies including oncologists, hematologist, surgeons, radiation oncologists, nurse practitioners, and other HCPs who in the course of their practice may see or refer these patients.

To bridge the gap between rsearch and patient care, this conference is an excellent opportunity to gain a better understanding of the recent advances and critical issues in oncology as well as new developments in scientific research and their potential impact on cancer care.  Experts in the fields of melanoma, breast, lung and genitourinary cancers will focus on key findings with the potential to change practice.  Participants will be provided with the necessary context to integrate the relevant information into their practices with a focus on patient-centered care.
 

 
SUPPORTERS
 
At press time, this activity is supported through educational grants from:

GENENTECH

BRISTOL MYERS SQUIBB

IMCLONE SYSTEMS 
 
 
Recent Developments in Cancer Therapies
 
©2007 Jabboury Foundation For Cancer Research Inc. | Powered by Elevology